Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome
Condition: Overactive Bladder Syndrome Interventions: Drug: Solifenacin Oral Tablet; Drug: Mirabegron 25mg Sponsor: Far Eastern Memorial Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2021 Category: Research Source Type: clinical trials
